Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Precision Biosciences Inc (NQ: DTIL )

1.500 +0.100 (+7.14%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 4, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 706,078
Open 1.420
Bid (Size) 1.450 (1)
Ask (Size) 1.490 (10)
Prev. Close 1.400
Today's Range 1.400 - 1.520
52wk Range 1.110 - 11.61
Shares Outstanding 110,818,008
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Precision BioSciences to Participate in Upcoming Jefferies Cell & Genetic Medicine Summit
From Precision BioSciences, Inc.
Via Business Wire
Precision BioSciences to Participate in Upcoming H.C. Wainwright 24th Annual Global Investment Conference
From Precision BioSciences, Inc.
Via Business Wire

Performance

YTD
-80.67%
-80.67%
1 Month
-1.96%
-1.96%
3 Month
-6.83%
-6.83%
6 Month
-52.83%
-52.83%
1 Year
-86.34%
-86.34%

More News

Read More
Precision BioSciences Announces Senior Leadership Organizational Changes
From Precision BioSciences, Inc.
Via Business Wire
Looking Into Precision BioSciences, Inc. - Common Stock's Return On Capital Employed
Via Benzinga
Why Precision BioSciences Shares Are Surging Today
Via Benzinga
Precision BioSciences: Q2 Earnings Insights
Via Benzinga
Precision BioSciences Reports Second Quarter 2022 Financial Results and Provides Business Update
From Precision BioSciences, Inc.
Via Business Wire
Earnings Preview: Precision BioSciences, Inc. - Common Stock
Via Benzinga
Precision BioSciences to Report Second Quarter 2022 Financial Results on August 8, 2022
From Precision BioSciences, Inc.
Via Business Wire
Precision BioSciences Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
From Precision BioSciences, Inc.
Via Business Wire
Global Pancreatic Cancer Therapeutics & Diagnostics Market Expected To Reach $5.6 Billion By 2027
Via FinancialNewsMedia
Precision BioSciences Announces Closing of Underwritten Offering of Common Stock
From Precision BioSciences, Inc.
Via Business Wire
This Healthcare Stock Jumps Around 188%, Here's 83 Biggest Movers From Yesterday
Via Benzinga
76 Biggest Movers From Yesterday: Ocean Bio-Chem, Athira Pharma And More
Via Benzinga
40 Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Exela Technologies (XELA) Stock Soars After Securing $136 Million Contract
Via InvestorPlace
Athira Pharma (ATHA) Stock Plunges 65% on Disappointing Drug Trial Results
Via InvestorPlace
Precision BioSciences (DTIL) Stock Treks Higher on Novartis Deal
Via InvestorPlace
Futures, Oil Tumble As Attention Turns To Coming Recession, Powell Senate Testimony
Via Talk Markets
The Daily Biotech Pulse: Precision BioSciences Inks Gene Editing Pact, Athira Pharma's Alzheimer's Candidate Fails, Enanta Sues Pfizer Over COVID-19 Antiviral
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Via InvestorPlace
21 Stocks Moving in Wednesday's Pre-Market Session
Via Benzinga
US Stock Futures Down; Powell Testimony In Focus
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.